Exact Mass: 761.3903779999999

Exact Mass Matches: 761.3903779999999

Found 33 metabolites which its exact mass value is equals to given mass value 761.3903779999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Lividomycin

LIVIDOMYCIN A SULFATE SALT

C29H55N5O18 (761.354193)

C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

Lividomycin A

LIVIDOMYCIN A SULFATE SALT

C29H55N5O18 (761.354193)

A member of the class of lividomycins that is lividomycin B in which position 4 of the diamino-L-idopyranosyl moiety has been converted into its alpha-D-mannopyranoside. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

pullularin C

C41H55N5O9 (761.399958)

5alpha-acetyloxy-8alpha-benzoyloxy-15beta-hydroxy-7beta-isobutanoyloxy-9alpha-nicotinyloxy-3beta-propanoyloxyjatropha-6(17),11E-diene-14-one|euphodendrophane H

C42H51NO12 (761.3411086)

(2S)-2-amino-3-[[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H64NO10P (761.4267613999999)

(2S)-2-amino-3-[[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H64NO10P (761.4267613999999)

(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H64NO10P (761.4267613999999)

PC 20:5/13:4;O2

C41H64NO10P (761.4267613999999)

PC 33:9;O2

C41H64NO10P (761.4267613999999)

LNAPS 34:9;O

C40H60NO11P (761.3903779999999)

LNAPS 35:8

C41H64NO10P (761.4267613999999)

PS 20:1/11:3;O3

C37H64NO13P (761.4115064)

PS 22:6/12:3;O

C40H60NO11P (761.3903779999999)

PS 31:4;O3

C37H64NO13P (761.4115064)

PS 34:9;O

C40H60NO11P (761.3903779999999)

SHexCer 32:4;O3

C38H67NO12S (761.4383742)

TFLLR-NH2(TFA)

C33H54F3N9O8 (761.404724)

TFLLR-NH2 (TFA) is a selective PAR1 agonist with an EC50 of 1.9 μM.

(3s,6s,12s,15s,18s,23as)-6,12-bis[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-(3h-imidazol-4-ylmethyl)-3-(2-methylpropyl)-15-[2-(methylsulfanyl)ethyl]-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-19-one

(3s,6s,12s,15s,18s,23as)-6,12-bis[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-(3h-imidazol-4-ylmethyl)-3-(2-methylpropyl)-15-[2-(methylsulfanyl)ethyl]-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-19-one

C36H59N9O7S (761.4257944000001)

2-{[5-amino-2-(aminomethyl)-6-({5-[(3,5-diamino-2-{[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl)oxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}oxy)-4-hydroxyoxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[5-amino-2-(aminomethyl)-6-({5-[(3,5-diamino-2-{[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl)oxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}oxy)-4-hydroxyoxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C29H55N5O18 (761.354193)

15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

C41H55N5O9 (761.399958)

2-({2-[(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

2-({2-[(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

C38H56ClN5O9 (761.3766356)

(3s,6s,9s,12s,15r,20as)-15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

(3s,6s,9s,12s,15r,20as)-15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

C41H55N5O9 (761.399958)